Home » Topics » BioWorld Science, Hematologic

BioWorld Science, Hematologic
RSS

XR-300 fibrinogen antagonist in preclinical testing

April 12, 1996

Merck & Co. describes fibrinogen antagonists

April 12, 1996

Fibrinogen antagonists from Yamanouchi

April 12, 1996

ATIII in development at Genzyme Transgenics

April 12, 1996

Neutralase to enter phase II

April 12, 1996

SB-214857 in preclinical studies

April 5, 1996

Scripps Research Institute reports fibrinogen antagonists

April 5, 1996

Platelet antiaggregatory prostaglandins reported by Taisho

April 5, 1996

Fibrinogen antagonists from E. Merck

March 15, 1996

First introduction for certoparin

March 15, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 25, 2026.
ADPD 2026: Can we prevent dementia? Scientists quantify it
BioWorld
Neurodegenerative disease and cognitive decline cannot be explained by a single process. Beta-amyloid plaques, hyperphosphorylated tau, alpha-synuclein, activated...
ADPD 2026: Three inflection points to target Alzheimer’s disease
BioWorld Science
A new way of understanding Alzheimer’s disease, based on biological inflection points that mark decisive moments in the progression of the disorder, could change...
Emerging therapeutic strategies for Parkinson’s at ADPD 2026
BioWorld
Parkinson’s disease (PD) involves the progressive loss of dopaminergic neurons, particularly in the substantia nigra. This neurodegeneration is linked to the...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 24, 2026